Hero Image

Occupiers

Granta Park’s reputation for providing the right mix of state-of-the-art laboratory facilities alongside superb amenity set within stunning parkland continues to attract leading organisations to locate here, including Nxera, Cancer Research UK, Illumina, Pfizer and PPD. Discover more about these organisations and others below:

Alloy Therapeutics

Alloy Therapeutics empowers scientists with access to pre-competitive biologics drug discovery technologies and services across six modalities.

Altos

Altos’ mission is to restore cell health and resilience through cell rejuvenation to reverse disease, injury and the disabilities that can occur throughout life.

Alzheimer's Research UK

Almost one million people are living with dementia today. Tragically, not one of them will survive.  Alzheimer’s Research UK, the UK’s leading dementia research charity, exists to change that. The charity’s mission is to accelerate progress towards a cure for dementia by revolutionising the way it is treated, diagnosed, and prevented.

Amphista

Amphista is identifying and advancing novel approaches in targeted protein degradation (TPD) to develop a new generation of innovative therapies.

Bicycle

Bicycle is developing precision-guided therapeutics, to penetrate deep into tissues and target intractable cancers.

Cancer Research UK

Cancer Research UK is the world's largest independent cancer research organisation. It funds scientists, doctors and nurses to help beat cancer sooner and provides cancer information to the public.

Gilead

Gilead focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

Illumina

Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Metrion

Metrion is a CRO specialising in ion channel screening, cardiac safety and neuroscience assays. They deliver high-quality data, expert analysis and collaborative support as an extension of your research team.

Nxera

Nxera’s mission is to accelerate the development of life-changing medicines by investing in science and technology.

Pfizer

Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.

Sphere Bio

Sphere Bio specialises in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, analysis and isolation.

Syngenta

Syngenta is a world leading life sciences company, applying unrivalled scientific expertise, knowledge, and capability through a range of advanced products and technologies to support sustainable agricultural practices globally.  By investing in cutting-edge research, fostering collaborations, and developing sustainable solutions, Syngenta is helping to secure the UK's future as a hub of scientific excellence and innovation for agricultural life sciences.

In the UK we employ 2500 people in life science research, advanced manufacturing, market deployment and enabling roles across eight sites.

Thermo Fisher

Thermo Fisher Scientific is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services.

T-Therapeutics

T-Therapeutics was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.

TWI

TWI is one of the world’s foremost independent research and technology organisations, with expertise in materials joining and engineering processes.

Vernalis

Vernalis Research develops and applies fragment and structure-based methods to drug discovery, and has generated cell active lead compounds and development candidates against biological targets in oncology, neurodegeneration, anti-infectives and inflammation.

Latest News
T-Therapeutics appoints Theodora Harold as Chief Executive Officer, reflecting Company’s ambitious growth plans and progression into therapeutic development
9 March, 2025
T-Therapeutics appoints Theodora Harold as Chief Executive Officer, reflecting Company’s ambitious growth plans and progression into therapeutic development
Sphere Fluidics rebrands to Sphere Bio
25 February, 2025
Sphere Fluidics rebrands to Sphere Bio
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform
11 February, 2025
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform

Park team

Our team is based on site at Granta Park, available daily and able to respond quickly to any queries. Ask them a question via our enquiry form or connect with them directly below.

Park team
Get in touch

Contact us

Contact us on +44 (0)1223 893 710 or use the form opposite to learn more about becoming a Granta Park tenant, discover more about Park life or explore other possibilities.